Items where Author is "Su, K"
 | Up a level |
Group by: Item Type | No Grouping
Number of items: 2.
Raza, S
Jokl, E
Pritchett, J 
ORCID: https://orcid.org/0000-0003-2620-7061
Martin, K
Su, K
Simpson, K
Birchall, L
et al.
ORCID: https://orcid.org/0000-0003-2620-7061
Martin, K
Su, K
Simpson, K
Birchall, L
et al.
Raza, S, Jokl, E, Pritchett, J ORCID: https://orcid.org/0000-0003-2620-7061, Martin, K, Su, K, Simpson, K, Birchall, L, Mullan, AF, Athwal, VS, Doherty, DT, Zeef, L, Henderson, NC, Kalra, PA, Hanley, NA and Hanley, KP
(2021)
SOX9 is required for kidney fibrosis and activates NAV3 to drive renal myofibroblast function.
Science Signaling, 14 (672).
ISSN 1945-0877
ORCID: https://orcid.org/0000-0003-2620-7061, Martin, K, Su, K, Simpson, K, Birchall, L, Mullan, AF, Athwal, VS, Doherty, DT, Zeef, L, Henderson, NC, Kalra, PA, Hanley, NA and Hanley, KP
Athwal, VS
Pritchett, J ORCID: https://orcid.org/0000-0003-2620-7061
Llewellyn, J
Martin, K
Camacho, E
Raza, SMA
Phythian‐Adams, A
et al.
ORCID: https://orcid.org/0000-0003-2620-7061
Llewellyn, J
Martin, K
Camacho, E
Raza, SMA
Phythian‐Adams, A
et al.
Athwal, VS, Pritchett, J ORCID: https://orcid.org/0000-0003-2620-7061, Llewellyn, J, Martin, K, Camacho, E, Raza, SMA, Phythian‐Adams, A, Birchall, LJ, Mullan, AF, Su, K, Pearmain, L, Dolman, G, Zaitoun, AM, Friedman, SL, MacDonald, A, Irving, WL, Guha, IN, Hanley, NA and Piper Hanley, K
(2017)
SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis.
EMBO Molecular Medicine, 9 (12).
pp. 1696-1710.
ISSN 1757-4676
ORCID: https://orcid.org/0000-0003-2620-7061, Llewellyn, J, Martin, K, Camacho, E, Raza, SMA, Phythian‐Adams, A, Birchall, LJ, Mullan, AF, Su, K, Pearmain, L, Dolman, G, Zaitoun, AM, Friedman, SL, MacDonald, A, Irving, WL, Guha, IN, Hanley, NA and Piper Hanley, K